Advances in the Management of Type 2 Diabetes Mellitus

  • Cyriac Thomas Marian Medical Centre, Pala.

Abstract

Diabetes mellitus is a chronic metabolic disorder of the endocrine system, characterized by a complex and varied pathophysiology. Worldwide, there is a dramatic increase in the number of patients with type 2 diabetes, and hence it is becoming a serious threat to the health of mankind. Commercially, a large number of drugs belonging to different classes, such as the Insulins, biguanides, sulfonylureas, meglitinides, and thiazolidinediones, DPP-4 inhibitors, SGLT2 INHIBITORS, and GLP1 AGONISTS are available to control and treat type 2 diabetic patients. However, none of these drugs are known to cure the diabetic phenotype completely. Furthermore, some of these agents can cause weight gain and have a limited role in the later stages of the disease. Newer formulations are reaching the market, which will help manage T2DM and improve patient outcomes.

Author Biography

Cyriac Thomas, Marian Medical Centre, Pala.

Consultant Physician, Department of Medicine

Published
2025-03-28
How to Cite
Thomas, C. (2025). Advances in the Management of Type 2 Diabetes Mellitus. Kerala Medical Journal, 18(1), 1-3. https://doi.org/10.52314/kmj.2025.v18i1.686